期刊文献+

惊恐障碍在综合性医院识别现状和艾司西酞普兰治疗效果 被引量:4

Panic disorder identification in general hospital and curative effect of escitalopram
下载PDF
导出
摘要 目的:探讨目前综合性医院临床各科室对惊恐障碍识别的临床分析和艾司西酞普兰在综合医院治疗惊恐障碍的有效性和安全性。方法:以胸闷、心慌、濒死感等不适主诉至我院就诊排除躯体疾病后转诊至医学心理科就诊268例患者,分析其中确诊为惊恐障碍的179例患者在临床各科室的首诊诊断构成,以及对其中168例惊恐障碍患者随机分为艾司西酞普兰组和帕罗西汀组,疗程8周,并用惊恐相关症状量表(PASS)、汉密尔顿焦虑量表(HAMA)、不良反应评定量表(SERS)对患者治疗前后进行评估。结果:确诊为惊恐障碍的179例患者在临床各科室的首诊诊断包括惊恐障碍、广泛性焦虑、抑郁症、心脏神经官能症、癔症、其他疾病等,首诊时诊断为惊恐障碍的患者仅占9.5%。患者在治疗1周、治疗2周艾司西酞普兰组的HAMA、PASS分值均低于对照组,而在治疗4、6、8周,两组患者的HA-MA、PASS分值差异无统计学意义(P>0.05)。在治疗8周时,艾司西酞普兰组治愈率为65.4%,有效率为91.4%,帕罗西汀组分别为63.7%,91.3%。两组差异无统计学意义。在不良反应方面,两组差异无统计学意义。结论:综合医院临床各科室对惊恐障碍患者首诊时的识别率较低。艾司西酞普兰治疗惊恐障碍疗效肯定,安全性较高。 Objective:To investigate panic disorder identification status in clinical divions of a general hospital,and to explore the efficacy and safety of escitalopram in treatment of panic disorder.Method:268 patients who saw a doctor for chest tightness,palpitation and inpending doom and were refered to the medical psychological department after excluding physical diseases were enrolled.179 patients were diagnosed as panic disorder and their first diagnosis were analysed.168 of 179 patients with panic disorder were randomly divided into two groups:study group were treated with escitalopram and the control group were treated with paroxetine.The treatment course was 8 weeks,all the subjects were rated by panic associated symptom scale(PASS),Hamilton rating scale for anxiety(HAMA) and rating scale for side effects(SERS) at the baseline and the end of week 1,2,4,6,8,respectively.Results:The first diagnosison 179 patients in clinical divisions included panic disorder,generalized anxiety,depression,cordis neurosis,hysterical psychosis and other diseases.The first diagnosis rate of panic disorder is 9.5%.Scale of HAMA,PASS in the study group was significantly lower than that in the control group at the end of the first two weeks,but there were no significant differences between the two groups in both clinical effect and side effects at the end of week 4,6,8(P〉0.05).The remission and response rates were 65.4% and 91.4% respectively in escitalopram group at the end of week 8 according to the HAMA score,while 63.7% and 91.3% respectively in paroxetine group,without statistical difference between the two groups.Conclusion:In general hospital clinical divisions,the first diagonsis correct rate of the panic disorder is very low,and panic disorder was easily misdiagnosed as other disease or disorder.Escitalopram is effective in treatment of patients with panic disorder and has better safety.
出处 《临床精神医学杂志》 2012年第2期128-130,共3页 Journal of Clinical Psychiatry
关键词 综合医院 惊恐障碍 艾司西酞普兰 general hospital; panic disprder; escitalopram
  • 相关文献

参考文献7

  • 1汪琴.貌似缺血性心脏病的焦虑症12例报道[J].实用全科医学,2004,2(1):56-56. 被引量:7
  • 2马希威,王立新,马振霞.50例惊恐障碍的临床特征分析[J].四川精神卫生,2005,18(2):102-102. 被引量:2
  • 3余常红,胡赤怡.惊恐障碍病人随访研究[J].中国心理卫生杂志,2002,16(9):614-615. 被引量:17
  • 4孙学礼主译.现代精神疾病诊断与治疗[M].北京:人民卫生出版社,2002.291-292.
  • 5中华医学会组织编著.精神病学高级教程[M]第1版.北京:人民军医出版社,2009:193.
  • 6Pollack MH.The pharmacotherapy of panic disorder[J].J Clinpsychiatry,2005,66(Sup4):S23-S27.
  • 7Kennedy SH,Andersen HF,Law RW.Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR:a meta-analysis[J].Psychiat Neurosci,2006,31:122-131.

二级参考文献13

  • 1汪向东 王希林 等.心理卫生评定量表手册增订版[M].北京:中国心理卫生杂志社,1999.134-142,161-167.
  • 2[1]Mavissakalian M, Perel JM. Clinical experiments in mainten a nce and discontinuation of imipramine therapy inpanic disorder with agoraphobia . Arch Gen Psychiatry 1992 Apr;49(4):318-23.
  • 3[2]John R Walker,G Ron Norton,Colin A Ross.Panic Disorders AND Agoraphob i a,P365. Brooks/Cole Publishing Company Pacific Grove,California 1991..
  • 4[3]Mavissakalian M, Perel JM. Protective effects of imipramine maintenan c e treatment in panic disorder with agoraphobia. Am J Psychiatry 1992 Aug;149(8 ):1053-7.
  • 5[4]Pollack MH, Otto MW, Tesar GE, et al. Long-term outcome after acute t r eatment with alprazolam or clonazepam for panic disorder.J Clin Psychopharmacol 1993 Aug;13(4):257-63.
  • 6[5]Keller MB, Hanks DL. Course and outcome in panic disorder.Prog Neuro psychopharmacol Biol Psychiatry 1993 Jul;17(4):551-70.
  • 7[6]Papp LA, Schneier FR, Fyer AJ,et al. Clomipramine treatment of panic disorder: pros and cons.J Clin Psychiatry 1997 Oct;58(10):423-5.
  • 8[7]Emmanuel NP, Ware MR, Brawman-Mintzer O,et al. Once-weekly dosing of f luoxetine in the maintenance of remission in panic disorder.J Clin Psychiatry 1999 May;60(5):299-301.
  • 9[8]Curtis GC, Massana J, Udina C, et al; Maintenance drug therapy of pani c disorder.J Psychiatr Res 1993;27 Suppl 1:127-42.
  • 10[9]Liebowitz MR. Panic disorder as a chronic illness.J Clin Psychiatry 1997;58 Suppl 13:5-8.

共引文献23

同被引文献44

  • 1杨海晨,高欢,余常红.西酞普兰治疗惊恐障碍对照研究[J].山东精神医学,2006,19(3):186-187. 被引量:4
  • 2赵文统,赵素梅.帕罗西汀治疗老年脑卒中后焦虑患者——30例临床观察[J].实用心脑肺血管病杂志,2007,15(3):203-204. 被引量:2
  • 3贾建平,崔丽英,王伟.神经病学[M].北京:人民卫生出版社,2010:203-205.
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准(第三版)[M].济南:山东科学技术出版社,2001.75-8.
  • 5刘力,李晓白,秦晓霞,毕红希.文拉法辛缓释剂和帕罗西汀治疗惊恐障碍的随机对照研究[J].中国新药与临床杂志,2007,26(10):768-771. 被引量:4
  • 6Baldwin DS, Anderson IM, Nutt D J, et al. Evidence - based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology [J]. J Psychopharmacol, 2005,19 (6) :567 - 596.
  • 7Culpepper I,. Identifying and treating panic disorder in primary care[J]. Clin Psychiatry, 2004,65 (Suppl 5 ) : 19 - 23.
  • 8刘协和.精神病学[M].第4版.北京:人民卫生出版社,2001:457-461.
  • 9Demyttenanere K, Bruffaerts R, Posada - Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the world health organiza- tion world mental health surveys[J]. JAMA,2004,291 (21 ) :2 581 - 2 590.
  • 10Royal Australian and New Zealand College of Psychiatrists Clinical Prac- tice Guidelines Team for Panic Disorder and Agoraphobia. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia[J]. Aust NZ J Psychiatry,2003,37(6) :641 -656.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部